GenMont Biotech Incorporation

TWSE:3164 Stock Report

Market Cap: NT$1.7b

GenMont Biotech Incorporation Dividends and Buybacks

Dividend criteria checks 1/6

GenMont Biotech Incorporation is a dividend paying company with a current yield of 3.58%.

Key information

3.6%

Dividend yield

0%

Buyback Yield

Total Shareholder Yield3.6%
Future Dividend Yieldn/a
Dividend Growth10.2%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareNT$0.700
Payout ratio124%

Recent dividend and buyback updates

Recent updates

We Think That There Are More Issues For GenMont Biotech Incorporation (TWSE:3164) Than Just Sluggish Earnings

Mar 19
We Think That There Are More Issues For GenMont Biotech Incorporation (TWSE:3164) Than Just Sluggish Earnings

Should You Or Shouldn't You: A Dividend Analysis on GenMont Biotech Incorporation (TPE:3164)

Apr 04
Should You Or Shouldn't You: A Dividend Analysis on GenMont Biotech Incorporation (TPE:3164)

GenMont Biotech Incorporation's(TPE:3164) Share Price Is Down 26% Over The Past Five Years.

Feb 14
GenMont Biotech Incorporation's(TPE:3164) Share Price Is Down 26% Over The Past Five Years.

Is GenMont Biotech Incorporation's (TPE:3164) Recent Price Movement Underpinned By Its Weak Fundamentals?

Jan 24
Is GenMont Biotech Incorporation's (TPE:3164) Recent Price Movement Underpinned By Its Weak Fundamentals?

Tread With Caution Around GenMont Biotech Incorporation's (TPE:3164) 3.5% Dividend Yield

Jan 03
Tread With Caution Around GenMont Biotech Incorporation's (TPE:3164) 3.5% Dividend Yield

Are GenMont Biotech Incorporation's (TPE:3164) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 08
Are GenMont Biotech Incorporation's (TPE:3164) Statutory Earnings A Good Guide To Its Underlying Profitability?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 3164 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 3164 has only been paying a dividend for 6 years, and since then payments have fallen.


Dividend Yield vs Market

GenMont Biotech Incorporation Dividend Yield vs Market
How does 3164 dividend yield compare to the market?
SegmentDividend Yield
Company (3164)3.6%
Market Bottom 25% (TW)1.8%
Market Top 25% (TW)4.6%
Industry Average (Biotechs)2.5%
Analyst forecast (3164) (up to 3 years)n/a

Notable Dividend: 3164's dividend (3.58%) is higher than the bottom 25% of dividend payers in the TW market (1.8%).

High Dividend: 3164's dividend (3.58%) is low compared to the top 25% of dividend payers in the TW market (4.58%).


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (123.8%), 3164's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (151.6%), 3164's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 15:52
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GenMont Biotech Incorporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan LuKGI Securities Co. Ltd.